Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SLC22A17 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
mRNA | CARNMT1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
mRNA | SRSF12 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0007 |
mRNA | PODXL2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
mRNA | TTC12 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |
mRNA | BAG3 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0007 |
mRNA | NRM | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
mRNA | PLXNA3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
mRNA | SPECC1L | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
mRNA | ZNF160 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |